Metabolic inflammation also involves PIEZO1, as shown by Zhao et al. [53], who reported that adipocyte-specific PIEZO1 activation in obesogenic conditions enhanced IL-6 and leptin secretion, contributing to systemic insulin resistance (Table 2). Here, PIEZO1 is linked to Insulin resistance.